Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33) (NCT07223398)
STOP (Shared Decision Making to Treat Or Prevent) HIV in Criminal Legal Involved Populations
๐ฉบ Plain-English Summary (8th-Grade Level)
This study seeks to compare the effectiveness of two Patient Navigation models of care to evaluate the proportion who initiate PrEP/ART and substance use/substance use disorder (SU/SUD) treatment. A standardized Patient Navigation (PN) arm will be compared with a shared decision-making model in the form of Patient Choice (PC) through the offer of a menu of existing community-based health service delivery options. This design will offer providers, correctional and public health authorities, payers and policy makers' timely and relevant data to assess the effectiveness of Patient Navigation and Patient Choice models of care as potentially useful re-entry and relapse prevention treatment options.
Who can join: Review the eligibility criteria below.
Location: Yale School of Medicine โ New Haven, Connecticut
Age range: 18 Years
๐งช Interventions in This Study
- Standard PN (BEHAVIORAL)
- Patient Choice (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (4 Sites)
- Yale School of Medicine โ New Haven, Connecticut
- College of Medicine at the University of Kentucky โ Lexington, Kentucky
- University of Texas Southwestern Medical Center (UTSW) โ Dallas, Texas
- Texas Christian University's (TCU) School of Medicine โ Fort Worth, Texas
๐ Contact the Study Coordinator
Phone: (203) 687-6680
Email: Sandra.springer@yale.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Substance Use Disorders
- Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients โ Ann Arbor, Michigan
- Ketamine for Methamphetamine Use Disorder โ San Leandro, California
- Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life With HIV and Substance Use โ Chicago, Illinois
- Evaluation of RRFT for Co-occurring SUD and PTSD Among Teens โ Aurora, Colorado
- IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs โ The Bronx, New York
- Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults โ Farmington, Connecticut
Explore by condition: All Substance Use Disorders clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.